Briefing
Circulating tumor DNA-guided therapeutic strategies for metastatic colorectal cancer patients with multiple small pulmonary-limited nodules: A prospective cohort study
In this prospective cohort of 70 patients with metastatic colorectal cancer limited to small pulmonary nodules, tumor-informed ctDNA clearance was associated with longer progression-free survival (12.6 vs 6.8 months). ctDNA also flagged extrapulmonary metastases a median of 5.5 months (range 2.8-9.2) before imaging. The authors state that these findings need prospective validation before they are used to guide treatment.
- Design: Evidence level 3
- Assay: Not named in the abstract
European Journal of CancerPubMed 42962410DOI 10.1016/j.ejca.2026.117793